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ABSTRACT
TRPM8 is a Ca2+-permeable nonselective cation channel belonging to the 
melastatin sub-group of the transient receptor potential (TRP) family. TRPM8 
is aberrantly overexpressed in a variety of tumor entities including glioblastoma 
multiforme where it reportedly contributes to tumor invasion. The present study 
aimed to disclose further functions of TRPM8 in glioma biology in particular upon cell 
injury by ionizing radiation. To this end, TCGA data base was queried to expose the 
TRPM8 mRNA abundance in human glioblastoma specimens and immunoblotting was 
performed to analyze the TRPM8 protein abundance in primary cultures of human 
glioblastoma. Moreover, human glioblastoma cell lines were irradiated with 6 MV 
photons and TRPM8 channels were targeted pharmacologically or by RNA interference. 
TRPM8 abundance, Ca2+ signaling and resulting K+ channel activity, chemotaxis, cell 
migration, clonogenic survival, DNA repair, apoptotic cell death, and cell cycle control 
were determined by qRT-PCR, fura-2 Ca2+ imaging, patch-clamp recording, transfilter 
migration assay, wound healing assay, colony formation assay, immunohistology, 
flow cytometry, and immunoblotting. As a result, human glioblastoma upregulates 
TRPM8 channels to variable extent. TRPM8 inhibition or knockdown slowed down 
cell migration and chemotaxis, attenuated DNA repair and clonogenic survival, 
triggered apoptotic cell death, impaired cell cycle and radiosensitized glioblastoma 
cells. Mechanistically, ionizing radiation activated and upregulated TRPM8-mediated 
Ca2+ signaling that interfered with cell cycle control probably via CaMKII, cdc25C 
and cdc2. Combined, our data suggest that TRPM8 channels contribute to spreading, 
survival and radioresistance of human glioblastoma and, therefore, might represent 
a promising target in future anti-glioblastoma therapy.
INTRODUCTION
Glioblastoma multiforme diffusely infiltrates 
the brain which confines complete surgical resection. 
Moreover, target volumes of adjuvant radiotherapy are 
limited by normal tissue toxicity and often do not include 
all brain-infiltrated residual glioblastoma cells. In addition 
to the highly migrating behavior of glioblastoma cells, 
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high intrinsic resistance to radio- and chemotherapy, most 
probably accounts for therapy failure and poor prognosis 
of glioblastoma patients (for review see [1]).
Glioblastoma cells have been demonstrated to over-
express certain ion channel types that are supposed to exert 
oncogenic functions (for review see [1]). Among 21 tested 
nonselective cation channels belonging to the transient 
receptor potential (TRP) super family, the melastatin 
family member 8 (referred to as TRPM8) showed highest 
upregulation in glioblastoma as compared to normal 
brain tissue [2]. TRPM8 has been originally identified 
as a cancer-associated gene in prostate carcinoma [3]. 
Meanwhile, there is increasing evidence that many tumor 
entities highly overexpress TRPM8 channels similar 
to glioblastoma [2]. Aberrantly expressed TRPM8 
channels have been proposed to contribute to epithelial-
mesenchymal-transition and metastasis of breast cancer 
[4], growth and metastasis of pancreatic adenocarcinoma 
[5], adaptation to hypoxia of prostate cancer [6], metastasis 
and chemotherapy resistance of osteosarcoma [7], poor 
prognosis of urothelial carcinoma [8], carcinogenesis of 
colon carcinoma [9], and migration of glioblastoma cells 
[10, 11]. Besides these malignancy-associated functions, 
TRPM8 reportedly suppresses survival of melanoma 
cells [12]. In addition, TRPM8 is highly upregulated in 
an early, differentiated stage but downregulated during 
malignant progression of prostate cancer [3, 13, 14] which 
might suggest that TRPM8 is involved in early prostate 
carcinogenesis but rather suppresses than promotes 
malignant progression. These apparently contradictory 
functions in tumor promotion and suppression suggest that 
TRPM8 may exert different functions in different tumor 
entities.
While in normal skin and peripheral neurons 
TRPM8 functions as a cold sensor (for review see [15]), 
the functions of TRPM8 in non-temperature-sensing 
organs such as normal prostate epithelium are not well 
defined. Reportedly, TRPM8 acts as an ionotropic 
testosterone receptor in the plasma membrane of prostate 
epithelium [16, 17] or osmosensor in peripheral neurons 
[18]. Similarly poorly understood are the mechanisms 
leading to upregulation of TRPM8 in cancer cells. In 
prostate cancer, TRPM8 mRNA abundance [14] and 
TRPM8 channel surface expression [19] are upregulated 
by androgens, in breast cancer by estrogens [20].
Reportedly, glioblastoma cell migration is motorized 
by synchronized volume increase at the lamellipodium 
and volume decrease at the opposite cell pole. These 
volume changes extrude the leading edge and retract 
the cell rear, thereby moving the glioblastoma cell 
along the cell rear-lamellipodium-axis. Ca2+-activated 
intermediate conductance (IK) and big conductance (BK) 
K+ channels exert a key role in this process pointing to a 
pivotal function of Ca2+ signaling for programming and 
mechanics of migration (for review see [21]). Moreover, 
ionizing radiation at doses used for single fractions of 
fractionated radiotherapy in the clinic has been shown to 
induce Ca2+ signals that are sufficient to activate BK and 
IK K+ channels and to induce migration of glioblastoma 
cells [22–24]. In addition, radiation-induced activation 
of IK K+ channels has been demonstrated to be required 
for cell cycle arrest and DNA repair since inhibition of 
IK K+ channels radiosensitizes glioblastoma cells [23]. 
Activation of TRPM8 by menthol has been shown to 
stimulate BK K+ channel activity and migration of 
glioblastoma cells [10, 11] suggesting that TRPM8 
functions as Ca2+ entry pathway in glioblastoma cells.
The present study, therefore, aimed to define in vitro 
the functional significance of TRPM8 for the Ca2+ and 
biochemical signaling in glioblastoma cells, involved in 
cell migration and chemotaxis on the one hand and in the 




First, we confirmed expression of TRPM8 and 
further TRP channels in glioblastoma by querying 
the glioblastoma multiforme database of The-Cancer-
Genome-Atlas (TCGA), and by analyzing protein 
expression in primary spheroid cultures of human 
glioblastoma specimens and mRNA expression in 
human glioblastoma cell lines (Supplementary Figure 
1). Combined, the data suggest a highly heterogeneous 
TRPM8 expression in human glioblastoma specimens 
and established glioblastoma cell lines. Among the human 
glioblastoma cell lines tested, p53-mutated U251 [25] 
(and in few experiments also p53 wildtype U-87 MG [25]) 
with relatively high and p53-mutated T98G cells [25] with 
relatively low TRPM8 mRNA abundance (Supplementary 
Figure 1D) were chosen for further functional studies.
TRPM8 induces activation of Ca2+-regulated K+ 
channels
TRPM8 agonists have been reported to stimulate 
the activity of BK Ca2+-regulated K+ channels in 
glioblastoma cells [10, 11]. Therefore, we determined 
the effect of the synthetic TRPM8 super-agonist 
icilin (3-(2-Hydroxyphenyl)-6-(3-nitrophenyl)-3,4-
dihydropyrimidin-2(1H)-one) on the BK K+ channel 
activity in the plasma membrane of T98G glioblastoma 
cells by patch-clamp on-cell (cell-attached) recording. 
TRPM8 activation by icilin is supposed to depolarize 
and via subsequent K+ channel activation to re- and 
hyperpolarize the physiological membrane potential. 
In on-cell recording mode, the physiological membrane 
potential can not be controlled and adds up with the clamp 
voltage. As a consequence, absolute membrane voltages 
are not exactly defined. Nevertheless, on-cell recording 
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mode is suited to analyze grossly voltage dependence or 
conductance of an ion channel.
As shown in Figure 1A-1D, the TRPM8 agonist 
icilin stimulated macroscopic on-cell outward currents in 
human T98G cells when recorded with Ca2+-containing 
NaCl solution in pipette and bath solution. This current 
was generated by K+-selective channels with a unitary 
conductance of about ~200 pS as deduced from the 
negative reversal potential and the slope of the current 
amplitude-voltage relationship in Figure 1E, 1F. Under 
control conditions, channel activity occurred only 
at highly depolarized voltages (Figure 1E, left) and 
open probability increased with increasing positive 
clamp-voltage (Figure 1G, open circles). Icilin induced 
channel activity already at 0 mV clamp-voltage, i.e., at 
physiological membrane potential, by changing the mean 
voltage of activation from +30 mV (control) to -15 mV 
(Figure 1E, right, and Figure 1G, 1H, closed triangles) 
without modulating the unitary conductance of the channel 
(Figure 1I). Since this K+ selective, voltage-dependent, 
and high conductance channel of T98G cells has been 
identified as Ca2+-activated and paxilline-sensitive BK K+ 
channel in our previous studies [22–24], our data confirm 
previous reports [10, 11] on the regulation of BK K+ 
channels by TRPM8.
TRPM8 promotes cell migration
BK K+ channels have been demonstrated to be 
key regulators of glioblastoma cell migration [22] and 
brain infiltration [24]. Moreover, TRPM8 agonists 
have been reported previously to stimulate migration 
of glioblastoma cells [10, 11]. We tested in the 
glioblastoma cell lines U-87MG and T98G whether cell 
migration and chemotaxis depend on TRPM8 channel 
activity. As shown in Figure 2A, TRPM8 channel 
activation by icilin increased and inhibition by the TRP 
channel blocker BCTC (N-(4-tertiarybutylphenyl)-
4-(3-cholorphyridin-2-yl)tetrahydropyrazine-1(2H)- 
carbox-amide) or downregulation by RNA interference 
decreased transfilter chemotaxis of T98G cells as 
induced by a fetal calf serum (FCS) gradient. Similarly, 
TRPM8 activation by icilin tended to increase migration 
speed of U-87MG and significantly accelerated 
migration speed of T98G cells in wound healing assays 
(Figure 2B-2E). Moreover, TRPM8 inhibition by 
BCTC significantly reduced the migration velocity of 
U-87MG and T98G cells. Likewise, downregulation 
of TRPM8 by RNA interference significantly slowed-
down the migration velocity of T98G cells (Figure 
2B-2E). Combined, these data clearly indicated a cell 
migration and chemotaxis-stimulating role of TRPM8 
channels in the human glioblastoma lines T98G and 
U-87MG confirming earlier reports on human DBTRG 
glioblastoma cells [10, 11].
TRPM8 confers radioresistance
To test for a radioresistance-modulating function of 
TRPM8, channel expression was experimentally down- 
and up- regulated in human U251 glioblastoma cells by 
transfection with siRNA specific for TRPM8 and the 
mRNA-binding protein MSI1 (Musashi-1), respectively. 
TRPM8 and MSI1 knockdown was paralleled by a marked 
decrease and increase in TRPM8 mRNA abundance, 
respectively (Figure 3A). The latter phenomenon could 
not be defined mechanistically. Nevertheless, MSI1 
knockdown was harnessed for experimental upregulation 
of TRPM8 in U251 cells. The functional significance of 
TRPM8 upregulation and downregulation was analyzed by 
monitoring the cytosolic free Ca2+ concentration as assessed 
by ratiometric fura-2 Ca2+ imaging during stimulation 
with the TRPM8 agonist icilin. TRPM8 upregulation and 
knockdown significantly increased and decreased the 
icilin-induced rise in intracellular free Ca2+ concentration, 
respectively, indicating functional expression of TRPM8 
in the plasma membrane of glioblastoma cells (Figure 3B).
Electro-, K+-, and Ca2+ signaling has been 
demonstrated to contribute to the stress response of 
tumors including glioblastoma upon treatment with 
ionizing radiation [22–24, 26]. Ionizing radiation has 
been demonstrated to activate TRP channels in leukemia 
cells [27, 28]. We, therefore, analyzed radiation-
induced changes in TRPM8 activity and abundance 
(Supplementary Figure 2). As a result, a single dose 
of 2 Gy increased TRPM8 activity in T98G cells and 
10 Gy total dose applied in 5 fractions stimulated 
TRPM8 abundance in T98G and U251 cells in vitro 
and in an orthotopic glioblastoma mouse model in vivo 
(Supplementary Figure 2) pointing to a radiation-induced 
upregulation of TRPM8 function in human glioblastoma.
Next, we studied whether TRPM8-mediated 
signaling might be involved in the stress response to 
ionizing radiation. Clonogenic survival of irradiated 
(0-6 Gy 6 MV photons) U251 cells was determined in 
dependence on TRPM8 expression by delayed plating 
colony formation. As a result, TRPM8 knockdown lowered 
the plating efficiency of U251 cells by 30% (Figure 
3C) and decreased the survival fraction of irradiated 
U251 cells (Figure 3C, 3D). In particular TRPM8 
knockdown decreased the survival fraction at 2 Gy (this 
is the clinically relevant dose applied in conventional 
fractionation schemes during fractionated radiotherapy) 
by some 30% (Figure 3E). Likewise, TRPM8 knockdown 
(Figure 3F, 3G) decreased plating efficiency by about 60% 
in T98G cells (Figure 3H) and survival fraction at 2 Gy by 
about 10% (Figure 3H-3J) in T98G cells.
To define whether TRPM8 knockdown-associated 
radiosensitization of U251 and T98G cells may result 
from impaired DNA repair, residual γH2AX foci as 
surrogate marker of residual DNA double strand breaks 
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Figure 1: TRPM8 agonist icilin stimulates BK K+ channel activity in human glioblastoma cells at physiological 
membrane potential. (A, B) Recording of macroscopic on-cell currents in human T98G glioblastoma cells. Depicted are the applied 
voltage-clamp pulse protocol (A) and tracings (B) recorded with NaCl bath and NaCl pipette solution further containing 0 μM (vehicle, left) 
or 10 μM (right) of the TRPM8 agonist icilin. In (B) only the currents evoked by voltage sweeps to -50, 0, +50 and +100 mV are shown. 
(C) Dependence of the mean macroscopic on-cell currents (± SE, n = 8-10) on the voltage recorded as in (A, B) from 0 μM (open circles) 
or 10 μM icilin-stimulated T98G cells (closed triangles). (D) Mean (± SE, n = 8-10) macroscopic on-cell conductance as determined for the 
outward currents in (C) of icilin (0 µM, open bar, or 10 μM, closed bar)-stimulated T98G cells. Conductances were calculated between +10 
and +60 mV voltage as shown by the grey lines in (C). * indicates p ≤ 0.05, two-tailed Welch-corrected t-test. (E) Single channel current 
transitions recorded as in (A) from T98G glioblastoma cells with 0 μM (vehicle) or 10 μM icilin in the pipette solution. Note, that the 
voltage-dependent increase in open probability is shifted towards more negative potentials in the icilin-stimulated (right) as compared to 
the vehicle-treated cells (left). (F, G) Dependence of the mean (± SE) unitary current transition (F, n = 7) and open probability (Po, G, n = 
4-7) on the voltage of the channels recorded as in (E) in the absence (open circles) or presence of icilin (closed triangle) (H, I) Activation 
voltage (H) and unitary conductance (I) of channels in vehicle- (open circles, n = 4) and icilin-treated (closed triangle, n = 7) T98G cells 
(given are individual recordings and the median values as grey lines).
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Figure 2: TRPM8 function is required for migration of human glioblastoma cells. (A, B) Time dependence (A) and slope of 
the mean (± SE, n = 4-8) impedance (B) as real-time measure of transfilter chemotaxis in T98G cells. Transfilter migration was performed 
either in the absence or presence of the TRPM8 agonist icilin (10 μM) or the TRP channel inhibitor BCTC (10 μM) as well as upon 
transfecting the cells with nt- or TRPM8 siRNA. (C) Light micrographs showing wound healing of the human glioblastoma cell line 
U-87MG at time 0 h (left) and 18 h (right) after scratching the monolayer. The white lines indicate the migration routes of 5 selected cells 
as recorded by time lapse microscopy. (D-F) Mean (± SE) migration speed during wound healing of U-87MG (D, n = 25-26) and T98G 
glioblastoma cells (E, F, n = 14-45). Wound healing was performed either in the absence (open bars) or presence of the TRPM8 agonist 
icilin (10 μM, grey bars) or the TRP channel inhibitor BCTC (10 μM, black bars, D, E) as well as upon transfecting the cells with nt- (open 
bar) or TRPM8 siRNA (closed bar, F). *, **, and *** indicate p ≤ 0.05, p ≤ 0.01, and p ≤ 0.001, ANOVA (B, D, E) or two-tailed t-test (F), 
respectively.
Oncotarget95901www.impactjournals.com/oncotarget
Figure 3: TRPM8 generates Ca2+ entry, increases clonogenic survival, and confers radioresistance to human glioblastoma 
cells. (A) Increase and decrease in housekeeper-normalized TRPM8 and MSI1 mRNA abundance of U251 cells following transfection with 
MSI1- (left, 4 individual experiments are depicted) and TRPM8 siRNA (right, means ± SE, n = 4; nt siRNA: non-targeting siRNA), 
respectively. (B) MSI1- and TRPM8 knockdown increases and decreases Ca2+ entry stimulated by the TRPM8 agonist icilin, respectively. 
Given are the mean (± SE, n = 16-19) fura-2 340/380 nm fluorescence ratios recorded in nt- (white), TRPM8- (black) or MSI1 siRNA-
transfected (grey) U251 glioblastoma cells before and during superfusion with the TRPM8 agonist icilin (10 μM, large plot). The insert 
shows the calculated slope of the fura-2 ratio/time relationship during icilin stimulation as a measure of Ca2+ entry. (C-E) Mean (± SE, 
n = 24-36) plating efficiency (C), radiation dose-dependent clonogenic survival (D), and survival fraction at 2 Gy (E) of nt- (white) and 
TRPM8 (black) siRNA-transfected U251 cells. (F, G) Transfection with TRPM8 siRNA effectively downregulates TRPM8 mRNA- (F) and 
protein abundance (G, right) in T98G cells. Given are housekeeper-normalized mean values (± SE, n = 4-8) of nt- (open bars) and TRPM8 
siRNA (closed bars)-transfected T98G cells (F and G, right) as well as a Western blot of whole cell lysates of two nt- and TRPM8 siRNA-
transfected T98G cells probed against TRPM8 and β-actin for loading control. (H-J) Mean (± SE, n = 24) plating efficiency (H), radiation 
dose-dependent clonogenic survival (I), and survival fraction at 2 Gy (J) of nt- (white) and TRPM8 (black) siRNA-transfected T98G cells. 
(K) TRPM8 is required for repair of DNA double strand breaks. Immunofluorescence micrographs stained against residual γH2AX foci 
(green) as measure of residual DNA double strand breaks in nt- and TRPM8 siRNA-transfected U251 cells 24 h after irradiation with 0 or 
4 Gy. Nuclei were counterstained with DAPI (blue). (L, M) Mean (± SE, n = 78-108) number of residual γH2AX foci plotted against the 
radiation dose of nt- (open circles) and TRPM8 siRNA-transfected (closed triangles) U251 (L) and T98G cells (M). *, **, and *** indicate p 
≤ 0.05, 0.01, and 0.001, respectively, two-tailed (Welch-corrected) t-test or ANOVA, where appropriate.
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were analyzed 24 h after irradiation with 0 and 4 Gy 
by immunofluorescence microscopy (Figure 3K). As a 
result, knockdown of TRPM8 significantly increased 
residual number of γH2AX foci by some 60% (U251, 
Figure 3L) and 20% (T98G, Figure 3M). In summary, 
these data indicate functional significance of TRPM8 
for DNA repair and clonogenic survival of irradiated 
glioblastoma cells. In accordance with the expression 
levels, effects of TRPM8 knockdown were higher in 
U251 with high TRPM8 expression than in T98G with 
low TRPM8 expression.
TRPM8 is required for cell survival
In addition to the management of genotoxic stress, 
TRPM8 seemed to exert survival signaling as evident 
from the impairment of plating efficiency in unirradiated 
cells by TRPM8 knockdown (see Figure 3C, 3H). To 
analyze possible anti-apoptotic functions of TRPM8, we 
compared in flow cytometry experiments the dissipation 
of the inner mitochondrial membrane potential (ΔΨm) 
and caspase activity as a measure of intrinsic apoptosis 
triggering and execution, respectively, between control (0 
Gy) or irradiated (4 Gy) nt- and TRPM8 siRNA-transfected 
U251 and T98G glioblastoma cells (Figure 4). As a result, 
TRPM8 knockdown significantly increased percentage of 
T98G and U251 cells with dissipated ΔΨm (Figure 4A-4C, 
open bars) and caspase activity (Figure 4D-4F, open bars). 
Ionizing radiation (4 Gy) had no or only minor additive 
effect on ΔΨm dissipation and caspase activation in nt 
siRNA-transfected or TRPM8 knockdown glioblastoma 
cells (compare 1st with 2nd bar and 3rd with 4th bar in Figure 
4B, 4C, 4E, 4F) indicating pivotal anti-apoptotic survival 
signaling by TRPM8 in unirradiated cells. Moreover, the 
data strongly suggest that the observed radiosensitization 
by TRPM8 knockdown could not simply result from 
accelerated apoptotic death of the irradiated glioblastoma 
cells.
TRPM8 signaling regulates cell cycle in 
unirradiated glioblastoma cells
Since, on the one hand, cell cycle progression 
is controlled by Ca2+ signaling and on the other hand 
impaired cell cycle regulation may result in inhibition of 
DNA repair and radiosensitization [26–29], the effect of 
TRPM8 knockdown on cell cycle distribution and DNA 
replication was analyzed in control and irradiated T98G 
and U251 cells. To this end, the cellular DNA content was 
measured in permeabilized cells by flow cytometry using 
the fluorescence dye propidium iodide (Nicoletti protocol, 
Figure 5A-5C) and the DNA replication by the base 
analogon 5-ethynyl-2′-deoxyuridine (EdU) incorporation 
(Figure 5D-5H). In unirradiated cells, TRPM8 knockdown 
decreased G1 population and increased G2 population in 
U251 and decreased S population and increased hyper 
G population in T98G cells (Figure 5B, 5C, open bars) 
suggestive of a TRPM8 function in mitosis.
Irradiation induces TRPM8-dependent S and 
TRPM8-independent G2/M cell cycle arrest, 
as well as a partially TRPM8-dependent 
accumulation of cells with increased DNA 
content
In both glioblastoma lines, irradiation increased 
the G2 and decreased the G1 population irrespective of 
TRPM8 knockdown (compare 1st with 2nd and 3rd with 
4th bar in the 1st and 3rd diagram of Figure 5B, 5C). In 
addition, radiation induced in nt siRNA- but not in 
TRPM8 siRNA-transfected cells an increase in S (U251 
and T98G) population. Together this indicates a radiation-
induced S and G2/M cell cycle arrest with the former 
being dependent on TRPM8. Moreover, in T98G but not 
in U251 cells, radiation and TRPM8 knockdown elevated 
the hyper G population in an additive manner. In U251 
cells, the TRPM8 knockdown increased hyper G only 
following irradiation (Figure 5B, 5C, 4th diagrams). The 
hyper G population represents cells with elevated DNA 
content. An increase in this population, therefore, hints to 
an impairment of mitosis or cytokinesis.
Irradiated (4 Gy) glioblastoma cells re-enter cell 
cycle after a time lag of 2 days
To directly test for a function of TRPM8 for the re-
entry in mitosis and cell division upon radiation-induced 
cell cycle arrest, T98G and U251 cells were irradiated (0 
or 4 Gy) and further incubated for 48 h. Thereafter, EdU 
(see above) was incubated for 8 h before EdU content of 
the DNA was determined by flow cytometry (Figure 5D). 
Irradiation (1st and 2nd bars in Figure 5E, 5F) resulted in 
an increase in EdU-negative S (U251 and T98G) and G2 
phase (U251) cells and in a decrease of EdU-negative G1 
cells (U251 and T98G, Figure 5E, 5F, 1st-3rd diagrams) 
while having no effect on the S and G2 phase cells that 
incorporated EdU (Figure 5E, 5F, 4th-5th diagrams). The 
latter observation suggests that G1/S transition and S 
phase progression (i.e., DNA replication) seemed to be 
restored to levels of unirradiated cells already 48-54 h 
after irradiation with 4 Gy.
TRPM8 contributes to S phase progression and 
mitosis
In both lines TRPM8 knockdown increased the 
EdU-negative S and G2 phase cells in irradiated and 
unirradiated cells (compare 1st with 3rd and 2nd with 4th bars 
in Figure 5E, 5F, 1st-2nd diagrams). In addition, TRPM8 
knockdown decreased in unirradiated U251 and T98G 
cells as well as in irradiated T98G cells the EdU-negative 
G1 population (compare 1
st with 3rd and 2nd with 4th bars 
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Figure 4: TRPM8 silencing induces breakdown of inner mitochondrial membrane potential (ΔΨm) and caspase 
activation in human glioblastoma cells. (A, D) Dot blots recorded by flow cytometry showing the TMRE (A) and the caspACE (D) 
fluorescence intensity as a measure of ΔΨm and caspase activity, respectively, in nt- (top) or TRPM8 (bottom) siRNA-transfected T98G 
cells 24 h after irradiation with 0 Gy (left) or 4 Gy (right). The insert in A depicts TMRE fluorescence histograms of 0 Gy (black) and 4 Gy 
(grey) irrradiated nt- (top) or TRPM8 (bottom) siRNA-transfected T98G cells. (B-C, E-F) Mean percentage (± SE, n = 17-18) of nt- (left) 
or TRPM8 (right) siRNA-transfected T98G (B, E) and U251 cells (C, F) cells 24 h after irradiation with 0 Gy (open bars) or 4 Gy (closed 
bars) exhibiting break-down of ΔΨm (B, C) or caspase activity (E, F). 
*** indicates p ≤ 0.001, ANOVA.
Oncotarget95904www.impactjournals.com/oncotarget
Figure 5: TRPM8 RNA silencing impairs cell cycle control in irradiated glioblastoma cells. (A) Histograms showing the 
cellular DNA content of nt- (top) or TRPM8 (bottom) siRNA-transfected U251 cells 48 h after irradiation with 0 Gy (black) or 4 Gy (grey) 
as determined by flow cytometry using propidium iodide as DNA-specific fluorescence dye. (B, C) Mean percentage (± SE, n = 17-18) 
of nt- (left) or TRPM8 (right) siRNA-transfected and 0 Gy- (open bars) or 4 Gy-irradiated (closed bars) U251 (B) and T98G cells (C) 
belonging to the G2, S, G1, or hyper G population. (D) Dot blots showing 5-ethynyl-2’-deoxyuridine (EdU) incorporation by nt- (top) or 
TRPM8 siRNA-transfected (bottom) and irradiated (0 or 4 Gy as indicated) U251 cells. 48 h after irradiation cells were incubated for 6 h 
with EdU (5 μM) before co-staining with propidium iodide and analysis by flow cytometry. Gray gates show the different cell populations. 
(E, F) Mean percentage (± SE, n = 6) of nt- (left) or TRPM8 siRNA-transfected (right) and 0 Gy- (open bars) or 4 Gy-irradiated (closed 
bars) EdU-negative (1st-3rd diagram) and EdU-positive (4th-5th diagram) U251 (E) and T98G (F) cells residing in S, G1, or G2 phase of 
cell cycle. (F, G, H) Ratios between EdU-positive and EdU-negative cells in U251 (G) and T98G (H) cells in dependence on TRPM8 
knockdown and irradiation. *, **, and *** indicate p ≤ 0.05, p ≤ 0.01, and p ≤ 0.001, respectively, ANOVA. # and ### indicate p ≤ 0.05 and p 
≤ 0.001, respectively, ANOVA after normalization to the mean TRPM8 siRNA 0 Gy value of independent experiments, n.t. indicates not 
significantly different.
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in Figure 5E, 5F, 1st-2nd diagrams). Moreover, TRPM8 
knockdown decreased in U251 cells the EdU-positive S 
and G2 population and in T98G cells the EdU-positive S 
population irrespective of irradiation (Figure 5E, 5F, 4th 
and 5th diagrams). The parallel increase and decrease in 
EdU-negative G2 and G1 population, respectively, again 
points to a role of TRPM8 in mitosis. Moreover, the 
TRPM8 knockdown-associated increase in EdU-negative 
S cells hints to an additional function of TRPM8 in S 
phase progression. Computing the ratio between EdU-
positive and EdU-negative cells revealed that irradiation 
alone did not change this ratio in nt siRNA-transfected 
U251 and T98G cells (compare 1st and 2nd bars in Figure 
5G, 5H) again pointing to a restored DNA replication 48-
54 h after irradiation. TRPM8 knockdown, in contrast, 
decreased the ratio between EdU-positive and EdU-
negative cells (compare 1st and 3rd bars in Figure 5F, 5H). 
In U251, but not in T98G cells, combined irradiation and 
TRPM8 knockdown further decreased this ratio (compare 
3rd and 4th bar in Figure 5F, 5H).
Together, the cell cycle data suggest a functional 
significance of TRPM8 channels in cell cycle control 
of unirradiated and irradiated glioblastoma cells. In 
both cell lines, TRPM8 knockdown increased the hyper 
G population of irradiated cells (see Figure 5B, 5C, 4th 
diagrams) which points to an impairment of mitosis or 
cytokinesis.
TRPM8 signals to the cdc2 subunit of the 
mitosis-promoting factor
To identify signaling pathways involved in the 
regulation of cell cycle by TRPM8, abundance and 
activity of Ca2+/calmodulin-dependent kinases-II isoforms 
(CaMKII), reported Ca2+ downstream effectors and their 
targets, the phosphatases cdc25C and cdc2 [30], were 
determined by immunoblotting in nt- or TRPM8 siRNA-
transfected T98G cells 4 h after irradiation with 0 or 2 
Gy. TRPM8 knockdown decreased CaMKIIs activity in 
control and irradiated cells as deduced from a decline in 
the Thr286-phosphorylated kinase proteins (Figure 6A, 1st 
and 2nd blot). Moreover, TRPM8 knockdown decreased the 
protein abundance of both, total and inactive, i.e., Ser216-
phosporylated cdc25C in control and irradiated T98G 
cells (Figure 6A, 3rd and 4th blot). In addition, irradiation 
increased the abundance of the inactive, i.e. Tyr15-
phosphorylated cdc2 subunit of the mitosis-promoting 
factor in nt- but not TRPM8 siRNA-transfected T98G 
cells (Figure 4A, 5th blot and Figure 6B, top). The effects 
of radiation and TRPM8 knockdown on abundance of total 
cdc2 protein were similar in trend (yet without reaching 
statistical significance, Figure 6A, 6th blot and Figure 6B, 
bottom). Likewise, radiation (2 Gy) induced within 4 h 
an increase in abundance of Tyr15-phosphorylated cdc2 
in nt- but not in TRPM8 siRNA-transfected U251 cells 
(Figure 6C, 1st blot and Figure 4D, top). Here, radiation 
of TRPM8 knockdown did not affect abundance of total 
cdc2 protein (Figure 6C, 2nd blot and Figure 6D, bottom). 
The data acquired in T98G cells suggest that TRPM8 is 
required for the activity of the CaMKII isoforms as well 
as the inactivating phosphorylation and abundance of 
the CaMKII target cdc25C. In T98G and U251, TRPM8 
knockdown consistently prevented radiation-induced 
inactivation of cdc2 by phosphorylation at Tyr15. Since 
p-(Tyr15)-cdc2 is a substrate of the phosphatase cdc25C 
[30], these data suggest a TRPM8-triggered signaling 
to cdc2 involving CaMKII and cdc25C in irradiated 
glioblastoma cells.
In summary, the data demonstrate that glioblastoma 
cells express TRPM8 channels, which exert pivotal 
functions in cell cycle control, prevention of apoptotic 
cell death, migration and chemotaxis, DNA repair and 
radioresistance.
DISCUSSION
The present study confirms previous data [10, 11] 
showing that TRPM8 channels constitute a Ca2+ entry 
pathway in glioblastoma cells and that TRPM8 channel 
activity stimulates glioblastoma cell migration. The new 
findings of our study are: i) TRPM8 signaling regulates 
cell cycle and represses apoptotic cell death. ii) Ionizing 
radiation with doses used in the clinic for fractionated 
radiation therapy of glioblastoma patients induces 
upregulation of TRPM8 function. iii) Elevated TRPM8 
function, in turn, confers radioresistance. iv) The latter 
might result from the observed dependence of cell cycle 
control during DNA damage response and DNA double 
strand break repair on TRPM8 signaling.
Combined, our observations suggest that TRPM8 
promotes brain invasion and confers radioresistance of 
glioblastoma cells. This assumption is in contradiction to 
a retrospective clinical study which concluded that higher 
TRPM8 mRNA abundance in the tumor associates with 
better overall survival of glioblastoma patients [2]. The 
interpretation of these clinical data, however, is largely 
limited due to low patient number (n = 33) which does 
not allow multivariate statistical testing (considering 
established prognostic and predictive parameters). 
Nevertheless, this previous study [2] demonstrated that 
among 20 TRP channels subtypes of the melastatin 
(TRPM), vanilloid (TRPV), and canonical (TRPC) 
family tested, TRPM8 showed highest upregulation in 
glioblastoma as compared to normal brain tissue strongly 
suggesting a pivotal function of TRPM8 in gliomagenesis.
Radiation-induced Ca2+ signaling
In addition to glioblastoma, chronic myeloid and 
T cell leukemia cells have been reported to respond to 
ionizing radiation with Ca2+ signaling that utilizes Ca2+-
permeable TRP channels [27, 28]. These TRP channels 
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Figure 6: TRPM8-mediated signaling contributes to radiation-induced inhibition of the mitosis-promoting complex.  
(A, C) Immunoblots of whole cell lysates from T98G (A) and U251 (C) cells (given are two individual samples for each condition) probed 
against p-(Thr286)-CaMKII, panCaMKII, p-(Ser216)-cdc25C, cdc25C (T98G), p-(Tyr15)-cdc2, cdc2 and for loading control against 
β-actin (T98G and U251). Cells were either transfected with nontargeting siRNA (nt-siRNA) or siRNA targeting TRPM8 (TRPM8 siRNA), 
irradiated with 0 or 2 Gy and lysed 4 h thereafter. (B, D) Mean (± SE, n = 4) β-actin-normalized protein abundances of p-(Tyr15)-cdc2 (top) 
and cdc2 (botton) in nt siRNA or TRPM8 siRNA-transfected T98G (B) and U251 (D) cells 4 h after irradiation with 0 Gy (open bars) or 4 
Gy (closed bars) * indicates p ≤ 0.05, ANOVA.
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have been suggested to regulate cell cycle progression and 
contribute to survival in concert with voltage-gated Kv3.4 
[29] or Ca2+-activated IK K+ channels [23, 26]. By re- or 
hyperpolarizing the plasma membrane, voltage-gated or 
Ca2+-activated K+ channels counteract Ca2+ entry-generated 
membrane depolarization. By doing so, these K+ channels 
maintain locally, i.e., in close vicinity to a Ca2+ entry 
pathway, a high inwardly directed electrochemical Ca2+ 
gradient across the plasma membrane. Hence, K+ channels 
regulate the activity of voltage-gated or voltage-dependent 
Ca2+ entry pathways and are, therefore, important players of 
the Ca2+-signalosome (for review see [1]).
Interaction between TRPM8, IK and BK K+ 
channels
In glioblastoma, ionizing radiation has been shown 
to activate BK [22, 24] and IK Ca2+-activated K+ channels 
[23]. Activities of both channels signal back to Ca2+ or 
biochemical signaling [26]. For instance, radiation-induced 
BK K+ channel electrosignaling has been demonstrated to 
be pivotal for the activation of downstream Ca2+ effector 
proteins such as the CaMKII isoforms and glioblastoma 
cell migration [22]. Radiation-induced IK electrosignaling, 
on the other hand, is reportedly required for cell cycle 
control, DNA damage repair and clonogenic survival 
[23]. Since TRPM8 function - as suggested by the 
present study - seems to be needed for both, migration 
and survival of irradiated cells, it is tempting to speculate 
that IK and BK K+ channels closely interact with TRPM8 
in glioblastoma cells. The cation permeability of the 
strongly outwardly rectifying TRPM8 channels decreases 
with hyperpolarizing voltages (for review see [15]). 
Therefore, a plausible scenario might be that IK and BK 
K+ channel activities hyperpolarize the plasma membrane 
and shut down TRPM8 channel-mediated Ca2+ influx. 
Decrease of Ca2+ influx, however, deactivates the Ca2+-
activated BK and IK K+ channels resulting in membrane 
re-depolarization. Depolarization again increases TRPM8-
mediated Ca2+-entry and reactivation of the K+ channels. 
Thus, reciprocal and interdependent activity of IK, BK, 
and TRPM8 may generate membrane voltage and Ca2+ 
oscillations specifically recognized by certain Ca2+ effector 
proteins such as CaMKII isoforms (for review see [1]). 
CaMKIIs, in turn, reportedly regulate glioblastoma cell 
migration [22, 31, 32] and mitosis [33].
TRPM8 and cell cycle control
The present study demonstrated an involvement 
of TRPM8 signaling in inhibition of the cdc2 subunit 
of the mitosis promoting factor possibly via inhibitory 
phosphorylation of the cdc25C phosphatase by CaMKII 
(see Figure 6).
Previous work of our laboratory demonstrated 
radiation-induced activation of CaMKII and 
hypermigration of T98G glioblastoma cells which was 
inhibited by the CaMKII blocker KN93 [22]. Notably, 
CaMKII activation and hypermigration, both, required 
radiation-induced BK K+ channel activity suggesting BK 
K+ channel signaling upstream of CaMKII [22]. In the 
present study, TRPM8 activity preceded BK K+ channel 
activation (see Figure 1), radiation stimulated TRPM8 
activity (see Supplementary Figure 2), and TRPM8 
knockdown prevented basal and radiation-induced 
CaMKII activity (see Figure 6). Combined, this argues for 
a TRPM8 - BK K+ channel - CaMKII signaling axis.
TRPM8 knockdown prevented radiation-induced 
inhibition of cdc2 activity as evident from a decrease 
in abundance of Tyr15-phosphorylated cdc2. This 
suggests that TRPM8 knockdown leads to an overriding 
of radiation-induced G2/M arrest. Accordingly, TRPM8 
knockdown and irradiation induced in flow cytometry 
experiments an increase in hyper G population indicative 
of an impairment of mitosis or cytokinesis (see Figure 5B, 
5C). It might be speculated that inhibition of G2/M cell 
cycle arrest by TRPM8 knockdown results in premature 
mitosis, i.e., mitosis with residual DNA damage eventually 
leading to mitotic catastrophe. The latter probably 
contributed to the observed radiosensitizing effect of 
TRPM8 knockdown. The effect of TRPM8 knockdown 
on radiation-stimulated increase in phospho-(Tyr15)-
cdc2 abundance, however, was lower in U251 than in 
T98G cells (see Figure 6B, 6D) while the radiosensitizing 
effect was much higher in U251 as compared to T98G 
cells. At least in U251 cells, this observation suggests 
further TRPM8-regulated radioprotective mechanisms. 
Among those might be a function of TRPM8 in DNA 
damage repair as deduced from the TRPM8 knockdown-
associated increase in residual number of radiation-
induced γH2AX foci. Notably, this increase was higher 
in U251 than in T98G cells consistent with the degree of 
TRPM8 knockdown-associated radiosensitization in both 
glioblastoma lines.
A function of Ca2+-permeable TRP channels for 
radiation-induced cdc2 inactivation and G2/M cell cycle 
arrest has been demonstrated in leukemia cells [27–29] 
suggesting that regulation of cdc2 by TRP channel-
mediated Ca2+ signals is a more common phenomenon 
and not limited to glioblastoma. In unirradiated T98G and 
U251 cells, TRPM8 knockdown delayed mitosis as evident 
from decrease and increase in EdU negative G1 and G2 
population, respectively, and inhibited S progression as 
apparent from a decrease in EdU incorporation. Combined, 
these data suggest that TRPM8-signaling regulates S 
progression and mitosis beyond radiation-induced G2/M 
cell cycle arrest. Notably, inhibition of IK Ca2+-activated 
K+ channels in unirradiated and irradiated T98G cells 
exerted effects on cell cycle progression [23] that differed 
from those observed upon TRPM8 knockdown pointing to 
a highly complex regulation of cell cycle by electro- and 
Ca2+ signaling in glioblastoma cells.
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TRPM8 activation in glioblastoma cells
In brain tumors the cold sensor TRPM8 is not 
exposed to low temperature, which is required to activate 
the channel in peripheral neurons. In addition, our 
experimental settings (e.g, migration, colony formation 
assays) did not subject the cells to any changes in 
osmolarity, suggesting that the documented osmosensing 
function of TRPM8 [18] can also not account for the 
observed TRPM8 activity in glioblastoma cells. TRPM8 
channel function is reportedly modulated by G-protein 
coupled receptors [34], phosphoinosites [15], serine/
threonine [35] and tyrosine kinases/phosphatases [36], as 
well as UBA1-dependent ubiquitination [19]. Moreover, 
protein-protein interactions with the two-transmembrane 
domain protein Pirt [37] and the TRP channel-associated 
factors (TCAFs) [38] reportedly promote trafficking 
and/or modulate activity of TRPM8. Finally, picomolar 
concentrations of testosterone have been shown to 
stimulate openings of the purified TRPM8 channel 
protein in planar lipid bilayers [16]. Combined, these 
data suggest a highly complex regulation of TRPM8 
surface expression and activity that might shift the set 
point of temperature-dependent activation towards body 
temperature. The exact molecular mechanisms leading to 
activation of TRPM8 in glioblastoma, however, are far 
from being understood.
Upregulation of TRPM8 expression by 
glioblastoma cells
Reportedly, TRPM8 is a target gene of the androgen 
receptor and p53 [14, 19]. The documented upregulation 
of the androgen receptor in glioblastoma [39] might 
therefore contribute to TRPM8 overexpression in the 
brain tumor. In U251 glioblastoma cells, downregulation 
of Musashi-1 (MSI1) was associated with upregulation of 
TRPM8 (see Figure 3A, 3B). This might hint to a possible 
negative regulation of TRPM8 by the RNA binding protein 
musashi-1. Querying the Cancer-Genome-Atlas for MSI1 
and TRPM8 mRNA abundances, however, did not confirm 
such an association in glioblastoma patient specimens 
(data not shown) suggesting that this phenomenon might 
be restricted to U251 cells. In the present study, TRPM8 
mRNA abundance increased significantly in T98G and 
U251 glioblastoma cells and not quite significantly 
in U-87MG cells during fractionated radiation (see 
Supplementary Figure 2C-2F) Similarly, fractionated 
radiation increased TRPM8 immunofluorescence in an 
orthotopic U-87MG-Katushka glioblastoma mouse model 
in vivo (see Supplementary Figure 2G). This suggests 
either selection of TRPM8 overexpressing and resistant 
glioblastoma cell clones or an adaptive response. The latter 
might in theory result from stabilization of p53. T98G and 
U251, which are p53-mutated [40], however, show higher 
fractionated radiation-induced increase in TRPM8 than 
p53 wildtype U-87MG cells, an observation which does 
not support a p53-mediated TRPM8 upregulation.
CONCLUSIONS
The present in vitro study proposes a possible 
functional significance of Ca2+-permeable TRPM8 
nonselective cation channels for glioblastoma survival, 
local tumor invasion, and radioresistance. Therefore, 
targeting TRPM8 alone or in combination with 
radiotherapy, possibly might be a promising new 
strategy for future anti-glioblastoma therapy. New and 
more specific pharmacological TRPM8 inhibitors are 
available [41, 42], antibodies binding to extracellular 
TRPM8 protein and inhibiting TRPM8 function have 
been developed [43] suggesting that TRPM8-targeting 
therapy, at least in theory, might be feasible. Whether 
or not TRPM8-targeting alone or in combination with 
radiotherapy has tolerable side effects and does effectively 
prolong survival has to await future preclinical studies in 
orthotopic glioblastoma animal models.
MATERIALS AND METHODS
Cell culture and transfection
Human T98G, U-87MG (both form ATTC) 
and U251 (kindly provided by Dr. Luiz Penalva, San 
Antonio, TX) glioblastoma cells were grown in 10% 
fetal calf serum (FCS)-supplemented RPMI-1640 (T98G 
and U-87MG) or DMEM (4500 mg glucose/l, U251) 
medium. Exponentially growing U251 and T98G cells 
were reversely transfected with stealth siRNAs (Thermo 
Fischer Scientific, Waltham, MA, U.S.A) specific for 
TRPM8 (HSS128188, HSS128189, HSS128190) and 
MSI1 (HSS106732, HSS106733, HSS106734), or 
with nt siRNA (Silencer® Select Negative Control 
No. 1 siRNA, #4390844, Ambion™, Thermo Fischer 
Scientific). Detached T98G and U251 cells (250,000 
in 2.5 ml RPMI-1640/10% FCS and DMEM (4500 mg 
glucose/l/10% FCS medium), respectively, were added to 
500 μl of pre-incubated (20 min/RT) Opti-MEM medium 
containing RNAiMAX lipofectamine (6 μl, Invitrogen 
Life Technologies, Carlsbad, CA, USA) and siRNA (25 
nM final concentration).
Quantitative RT-PCR
Messenger RNAs of TRPM8 siRNA-, MSI1 siRNA- 
or nt siRNA-transfected U251 and T98G cells (48-72 h 
after transfection) were isolated (Qiagen RNA extraction 
kit, Hilden, Germany) and reversely transcribed in cDNA 
(Transcriptor First Strand cDNA Synthesis Kit, Roche, 
Mannheim, Germany). TRPM8-, MSI1 (Musashi-1)-, 
as well as housekeeper β-actin (ACTB)-, pyruvate 
dehydrogenase beta (PDHB)-, and glyceraldehyde-3-
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phosphate dehydrogenase (GAPDH)-specific fragments 
were amplified by the use of SYBR Green-based 
quantitative real-time PCR (QuantiTect Primer Assays 
QT00038906, QT00003780, QT00095431, QT00031227, 
and QT01192646 and QuantiFast SYBR Green PCR 
Kit, Qiagen) in a Roche LightCycler Instrument (Roche, 
Mannheim, Germany). mRNA abundances were 
normalized to the geometrical mean abundance of the 
three housekeepers.
Patch clamp recording
On-cell currents of semi-confluent T98G cells 
were elicited by 41 voltage square pulses (700 ms each) 
delivered in 5 mV increments from 0 mV holding potential 
to voltages between -100 mV and +100 mV. Voltages 
refer to the intracellular face of the plasma membrane. 
Flow of positive charge out of the cells (or the counter 
flow of anions) is defined as positive current and depicted 
as upward deflection of the current tracings. Cells were 
superfused at 37°C with Ca2+-containing NaCl solution (in 
mM: 125 NaCl, 32 HEPES, 5 KCl, 5 d-glucose, 1 MgCl2, 
1 CaCl2, titrated with NaOH to pH 7.4). This NaCl solution 
was also used for the pipette solution further containing 0 
or 10 μM icilin (in 0.1% DMSO). Macroscopic on-cell 
currents were analyzed by averaging the currents between 
100 and 700 ms of each square pulse.
Migration assay
For transfilter chemotaxis, the lower and upper 
chamber of a CIM-Plate 16 (Roche, Mannheim, Germany) 
were filled with 160 μl (lower chamber) and 100 μl (upper 
chamber) of RPMI-1640 medium containing 5% and 
1% FCS, respectively, equilibrated at 37°C and 5% CO2 
for 30-60 min. After CO2 equilibration and resetting the 
impedance to zero, 100 μl of cell suspension containing 
40.000 TRPM8- or nt siRNA-treated T98G cells (48 h 
after transfection) in RPMI-1640/1% FCS were added to 
the upper chamber. After sedimentation and adherence of 
the cells, migration was analyzed. The upper and lower 
chamber additionally contained icilin, or the TRPM8 
inhibitor N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)
piperazine-1-carboxamide, BCTC (all 0 or 10 μM in 0.1% 
DMSO). Transfilter migration was assessed by measuring 
the electrical impedance increase between electrodes that 
cover the lower surface of the filter membrane (i.e., the 
bottom of the upper chamber) and the reference electrode at 
the bottom of the lower chamber. Upon transfilter migration, 
cells adhere to the electrode at the lower surface of the filter 
membrane and, thereby, increase the impedance.
For cell migration during wound healing, control 
(T98G, U-87MG) and TRPM8- or nt siRNA-treated 
T98G glioblastoma cells were plated in 35 mm dishes 
(120.000 cells per insert) with culture inserts (Ibidi, 
Martinsried, Germany). After monolayer formation, cells 
were pretreated (30 min) with TRPM8 activator icilin or 
inhibitor BCTC (all 0 or 10 μM in 0.1% DMSO) in phenol 
red-free 20 mM HEPES (pH 7.4)-supplemented RPMI-
1640 medium. Migration assay was started by removing 
the inserts to create a wound of approximately 500 μm in 
width. Thereafter (0 - 18 h), 3 fields of the wound were 
photographed with an inverse light microscope every 30 
min (Axio Observer.Z1, 10x, Zeiss, Jena). For each field 
5 cells were tracked (Manual Tracking, ImageJ) and the 
velocity was calculated.
Fura-2 fluorescence imaging of free[Ca
2+]i
Fluorescence measurements were performed at 37°C 
using an inverted phase-contrast microscope (Axiovert 
100; Zeiss, Oberkochen, Germany). Fluorescence was 
evoked by a filter wheel (Visitron Systems, Puchheim, 
Germany)-mediated alternative excitation at 340/26 or 
387/11 nm (AHF, Analysentechnik, Tübingen, Germany). 
Excitation and emission light was deflected by a dichroic 
mirror (409/LP nm beam splitter, AHF) into the objective 
(Fluar x40/1.30 oil; Zeiss) and transmitted to the camera 
(Visitron Systems), respectively. Emitted fluorescence 
intensity was recorded at 587/35 nm (AHF). Excitation 
was controlled and data acquired by Metafluor computer 
software (Universal Imaging, Downingtown, PA, USA). 
The 340/380-nm fluorescence ratio was used as a measure 
of cytosolic free Ca2+ concentration (free[Ca
2+]i). TRPM8- , 
MSI1- or nt siRNA-transfected U251 cells (24 h (MSI1) 
and 48 h (TRPM8) after transfection) were incubated with 
fura-2/AM (2 μM for 30 min at 37°C; Molecular Probes, 
Goettingen, Germany) in DMEM/10% FCS medium, 
respectively. Steady state free[Ca
2+]i was recorded in Ca
2+-
containing NaCl solution (see above) before and during 
superfusion of icilin (10 μM).
Ionizing radiation
Exponentially growing T98G, and U251 cells were 
irradiated (single dose of 0, 2, 4 and 6 Gy) with 6 MV 
photons by using a linear accelerator (LINAC SL25 
Philips) at a dose rate of 4 Gy/min at room temperature. 
Open-field irradiation was applied. For a sufficient dose 
buildup in the plane of the cells, a RW3 slab (1 cm thick) 
was placed above the cells. Energy deposition at the cell 
plane was calibrated by film dosimetry. Following IR, cells 
were post-incubated in the respective cell culture media 
for 4 h (immunoblotting), 24 h (immunofluorescence 
microscopy), 48 h (flow cytometry, Nicoletti protocol), 
54 h (flow cytometry, EdU incorporation), or 2-3 weeks 
(colony formation assay).
Colony formation assay
To test for clonogenic survival, TRPM8-, or nt 
siRNA-transfected U251 and T98G cells (48 h after 
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transfection) were irradiated (0, 2, 4 or 6 Gy) in the 
respective cell culture media. Twenty-four hours after 
IR, 400 and 600 (T98G) or 1200 (U251) cells were 
re-seeded on 6-well plates and grown for further 2-3 
weeks. Clusters of ≥ 50 cells were defined as colony. 
Colonies were counted manually. The plating efficiency 
was defined by dividing the number of colonies by the 
number of plated cells. Survival fractions as calculated 
by dividing the plating efficiency of the irradiated cells 
by those of the unirradiated controls were fitted by 
SigmaPlot (Systat Software GmbH, Erkrath, Germany) 
to the linear quadratic equation S = e^–(α·D + ß·D2) with 
S being the survival fraction, D the radiation dose, and 
α,·ß tissue constants.
Immunoblotting
Whole protein lysates were prepared from 
semiconfluent irradiated (0 or 2 Gy) nt- or TRPM8 
siRNA-transfected T98G and U251 cells (48-72 h and 4 
h after transfection and irradiation, respectively) using a 
buffer containing (in mM) 50 HEPES pH 7.5, 150 NaCl, 
1 EDTA, 10 sodium pyrophosphate, 10 NaF, 2 Na3VO4, 
1 phenylmethylsulfonylfluorid (PMSF) additionally 
containing 1% Triton X-100, 5 μg/ml aprotinin, 5 μg/
ml leupeptin, and 3 μg/ml pepstatin (all Sigma-Aldrich), 
and separated by SDS-PAGE under reducing conditions. 
Segregated proteins were electro-transferred onto PVDF 
membranes (Roth, Karlsruhe, Germany). Blots were 
blocked in tris(hydroxymethyl)aminomethane-buffered 
saline (TBS) buffer containing 0.05% Tween 20 and 
5% non-fat dry milk for 1 h at room temperature. The 
membranes were incubated overnight at 4°C with the 
following primary antibodies: rabbit anti TRPM8- 
(Abcam #3243, Biomol Hamburg, Germany, 1:1000), 
rabbit anti-phospho-CaMKII (Thr286)- (#3361, Cell 
Signaling, New England Biolabs, Frankfurt, Germany, 
1:500), rabbit anti-CaMKII (pan)- (#3362, Cell 
Signaling, 1:500), rabbit anti-phospho-cdc25C (Ser216)- 
(#4901, Cell Signaling, 1:1000), rabbit anti-cdc25C 
(5H9)- (#4688, Cell Signaling, 1:1000), rabbit anti-
phospho-cdc2 (Tyr15)- (#9111, Cell Signaling, 1:1000), 
rabbit anti-cdc2- (#9112, Cell Signaling, 1:1000), or 
mouse anti- β-actin antibody (#A5441, Sigma Aldrich, 
Deisenhofen, Germany, 1:30,000). Antibody binding 
was detected with a horseradish peroxidase (HRP)-
linked goat anti-rabbit or HRP-linked goat anti-mouse 
IgG antibody (Cell Signaling # 7074 and # #7076, 
respectively; 1:1000 - 1:2000 dilution in TBS-Tween 
/ 5% milk) incubated for 1 h at room temperature and 
enhanced chemoluminescence (ECL Western blotting 
analysis system, GE Healthcare/Amersham-Biosciences, 
Freiburg, Germany). Indicated protein levels were 
quantified by densitometry using ImageJ software 
(ImageJ 1.40g NIH, USA).
Immunofluorescence microscopy of residual 
DNA double strand breaks
Nt- and TRPM8 siRNA-transfected U251 or T98G 
cells (1500 cells per well) were seeded on a Millicell 
EZ SLIDE 8-well glass (Merck Millipore, Tullagreen, 
Ireland) and grown for 48 h, irradiated with 0 and 4 Gy, 
and further incubated for 24 h. Thereafter, cells were fixed 
with 3.7% formaldehyde for 15 min at 21°C followed by 
three washing steps with phosphate buffered saline (PBS). 
Next, cells were permeabilized for 10 min at 21°C with 
0.1% Triton-X 100 in PBS followed again by three washing 
steps with PBS. Cells were probed against γH2AX using 
anti-γH2AX (Ser139) antibody (monoclonal mouse, clone 
JBW301, #05-636, Merck Millipore, Darmstadt, Germany) 
in a 1:1000 dilution. Antibody binding was visualized with 
the Tyramide Signal Amplification Kit (Molecular Probes, 
Eugene, Oregon, USA). Prior to mounting, nuclei were 
counterstained with DAPI (Sigma-Aldrich).
Flow cytometry
To determine ΔΨm and caspase activity after 
irradiation T98G and U251 cells were transfected 
with TRPM8- or nt siRNA, irradiated (48 h after 
transfection, 0 or 4 Gy) and incubated for further 24 h 
in the respective cell culture media. To determine ΔΨm, 
cells were trypsinated, washed and incubated for 30 min 
at room temperature in Ca2+-containing NaCl solution 
solution (see above) containing the ΔΨm-specific dye 
tetramethylrhodamine ethyl ester perchlorate (TMRE, 
25 nM for 30 min, Invitrogen, Karlsruhe, Germany). 
To assess caspase activity, cells were detached and 
incubated with CaspACE TM FITC-VAD-FMK (5 μM 
for 30 min in cell culture medium, Promega, Mannheim, 
Germany). TMRE and CaspaACE-specific fluorescence 
was measured by flow cytometry (FACS Calibur, Becton 
Dickinson, Heidelberg, Germany, 488 nm excitation 
wavelength) in fluorescence channel FL-2 (585/42 nm) 
and FL-1 (530/30 nm) emission wavelength, respectively.
Cell cycle analysis
For cell cycle analysis, irradiated TRPM8- or nt 
siRNA transfected T98G and U251 cells (0 or 4 Gy, 48 h 
after IR and 96 h after transfection) were permeabilized 
and stained (30 min at room temperature) with propidium 
iodide (PI) according to the Nicoletti protocol (containing 
0.1% Na-citrate, 0.1% triton X-100, 10 μg/ml PI in 
RNase-containing phosphate-buffered saline, PBS), 
and the DNA amount was analyzed by flow cytometry 
in fluorescence channel FL-3 (>670 nm, linear scale). 
Data were analyzed with the FCS Express 3 software 
(De Novo Software, Los Angeles, CA, USA). For EdU 
incorporation, irradiated TRPM8- or nt-siRNA transfected 
T98G and U251 cells (0 or 4 Gy, 48 h after IR and 96 
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h after transfection) were incubated for further 6 h in 
the respective cell culture media additionally containing 
the base analogon 5-ethynyl-2’-deoxyuridine (EdU, 5 
μM). EdU incorporation was analyzed by the use of 
an EdU flow cytometry kit (BCK-FC488, baseklick, 
Tutzing, Germany) after fixing the cells and co-staining 
the DNA with propidium iodide (PI, Sigma-Aldrich) 
according the manufacturer’s instructions. EdU- and PI-
specific fluorescence were recorded by flow cytometry in 
fluorescence channel FL-1 (log scale) and FL-3 (linear 
scale), respectively.
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